Clinical Trial Update: Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a piroxicam-beta-cyclodextrin formulation for reducing tooth sensitivity caused by in-office bleaching has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tooth Sensitivity
• Toothache

Drugs mentioned

• Piroxicam-beta-Cyclodextrin (piroxicam-beta-cyclodextrin)

Snippet

Sponsor: Universidade Federal de Sergipe | Conditions: Tooth Sensitivity, Toothache | Phase 3 | Status: COMPLETED